MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$146,930K
Stock-based compensation
$20,026K
Deferred income tax
provision
-$11,020K
Depreciation and
amortization
$8,096K
Accrued expenses
$5,212K
Loss on
extinguishment of debt
-$3,336K
Accounts payable
$2,330K
Amortization of debt discount
$717K
Deposits and other assets
-$279K
Loss on disposal of
fixed assets
-$9K
Net cash provided by
operating activities
$50,396K
Canceled cashflow
$147,559K
Net (decrease)
increase in cash and cash...
-$15,517K
Canceled cashflow
$50,396K
Jpm term loan
proceeds-JPMCredit Facilities
$75,000K
Ares revolving
facility proceeds-Ares...
$30,000K
Net proceeds from
the exercise of...
$2,984K
Deposit received on net
assets held for sale
$1,000K
Accounts receivable
$108,430K
Inventories
$36,230K
Prepaid expenses and
other current assets
$1,525K
Other current and
non-current liabilities
-$1,231K
Amortization of license
revenue
-$143K
Net cash used in
financing activities
-$44,022K
Canceled cashflow
$107,984K
Net cash used in
investing activities
-$21,891K
Canceled cashflow
$1,000K
Ares revolving
facility payments-Ares...
$72,500K
Term loan
payments-Ares Credit Facility
$32,500K
Acquisition of treasury
stock
$31,940K
Taxes paid on vested
restricted stock units
$9,547K
Debt issuance costs
$2,237K
Payment of end of term fee
$1,313K
Prepayment penalties on
repayment of debt
$1,031K
Term loan
payments-JPMCredit Facilities
$938K
Purchase of property and
equipment
$22,575K
Acquisition of intangible
assets
$316K
Back
Back
Cash Flow
source: myfinsight.com
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)